PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Jun-2021 Charles River Laboratories Announces Long-Term Solar Contract for North American Operations Businesswire
07-Jun-2021 Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel Businesswire
07-Jun-2021 Melior Pharmaceuticals Announces Entry Into “Letter-of-Intent” for the Acquisition of Armesocarb by Adhera Therapeutics Businesswire
07-Jun-2021 Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance) Businesswire
07-Jun-2021 Exelixis et Ipsen présentent lors de la réunion de l’ASCO 2021 les résultats détaillés de l’étude de Phase III évaluant le cabozantinib chez des patients atteints d’un cancer de la thyroïde différencié Businesswire
07-Jun-2021 Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents Businesswire
07-Jun-2021 Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union Businesswire
07-Jun-2021 Reven Announces New Chief Operating Officer Businesswire
07-Jun-2021 DTx Pharma Appoints Jill Howe as Chief Financial Officer Businesswire
07-Jun-2021 New Data on KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Versus Sunitinib in First-Line Treatment for Patients With Advanced Renal Cell Carcinoma From Pivotal Phase 3 CLEAR/KEYNOTE-581 Trial Presented at 2021 ASCO Annual Meeting Businesswire
07-Jun-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
05-Jun-2021 KalVista Pharmaceuticals Presents Phase 2 Clinical Data of Oral KVD900 for Treatment of HAE at C1-Inhibitor Deficiency & Angioedema Workshop Businesswire
05-Jun-2021 3 Exclusive Speaker Interviews Released ahead of Microbiology West Coast Virtual Conference in 2 weeks SMi Group
05-Jun-2021 FREQUENCY THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Businesswire
04-Jun-2021 BioAro Inc. and CardiAI Launches Rapid PCR Testing Services in the Northwest Territories at Gahcho Kué Mine: Businesswire
04-Jun-2021 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Businesswire
04-Jun-2021 SHAREHOLDER ALERT: Robbins LLP Announces that Frequency Therapeutics, Inc. (FREQ) is Being Sued for Misleading Shareholders Businesswire
04-Jun-2021 AmerisourceBergen to Participate in Upcoming Investor Conferences Businesswire
04-Jun-2021 Notice of Lead Plaintiff Deadline for Shareholders in the Frequency Therapeutics, Inc. Class Action Lawsuit Businesswire
04-Jun-2021 With Hundreds of Bio Industry Jobs Open and Company Expansions Underway, Companies Are Investing in Industry-Intensive Training and Professional Development Businesswire